...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Message: Resverlogix Repays $68.8 Million Loan

Kelsey - it's only $68.8 mil of debt and some working capital. They have worked hard on this man, don't take their glory away. We have all been looking forward to this. We can only hope the momentum continues until the FA is released.


New Message
Please login to post a reply